HomeCLINICAL TRIALS, STUDIES, REGISTRIES, DATA

CLINICAL TRIALS, STUDIES, REGISTRIES, DATA

NeuroOne Medical Technologies Corporation Announces Successful Completion of Feasibility Study for Ablation Electrode

Dr. Robert Gross of Emory says, "This pilot study will provide important data to inform the development of this technological solution that has the potential to improve treatment efficacy and patient comfort."

Medtronic Enrolls 1st Patient Completing 1st Surgical Procedure in its BRAIVE™ IDE Study

The device is Medtronic's latest innovation in the pediatric spine category, and the study's initiation reaffirms the company's commitment to continued innovation for pediatric patients.

Japanese SELUTION SLR™ Study Completes Enrollment

The study involves 133 patients across 13 centers in Japan. Its objective is to assess the safety and efficacy of SELUTION SLR for the treatment of lesions of superficial femoral arteries and/or popliteal arteries.

TheraSphere™ Y-90 Glass Microspheres Late Breaking Data

EPOCH trial represents the first positive phase 3 study for selective internal radiation therapy.

SPACE-AF Study Update: Galaxy Medical Reports 1st Patient Is Enrolled

Atul Verma, MD, Head of the Heart Rhythm program at Southlake Regional Health Centre and Primary Investigator in the SPACE-AF study commented: "We are thrilled to launch the first study of focal ablation through a solid tip catheter with PEF to treat both the pulmonary veins and atrial targets beyond the pulmonary veins including the left atrial posterior wall.

New Study Shows Consistent Medical-Grade Accuracy and Environmental Benefits to Replacing Mercury Sphygmomanometers with OMRON HEM-907XL

Published research supported by the CDC highlights environmental and cost-savings benefits of replacing mercury sphygmomanometers with electronic blood pressure monitors.

CureApp Hypertension Therapeutics App: Clinical Trial Results Published in the European Heart Journal

Japan’s first major leap toward digital therapeutics in the field of hypertension .

Miach Orthopaedics Initiates Post-Market Study for BEAR® Implant

Miach Orthopedics initiated BEAR III to continue to build upon the extensive base of evidence for the BEAR Implant, which recently received De Novo approval from the U.S. Food and Drug Administration.

Results of a Dual-Site Study Involving the Non-Invasive vMap System™ During SAbR Published In Heart Rhythm O2

An article published by the Heart Rhythm Society’s journal Heart Rhythm O2 concludes that Vektor’s Computational ECG Mapping System (vMap™) and protocol-based respiratory gating may help facilitate radioablation planning and maintain efficacy during therapy.